Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-13 Purchase | 2023-04-14 06:00 am | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 30,000 | $0.2987 | $8,961 | 163,219 (Indirect Direct) | View |
| 2022-03-24 Purchase | 2022-03-28 4:00 pm | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 5,000 | $1.4421 | $7,210 | 94,522 (Indirect Direct) | View |
| 2022-01-27 Purchase | 2022-01-31 4:00 pm | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 12,500 | $1.73 | $21,625 | 89,522 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-17 Option Award | 2024-09-19 6:30 pm | N/A 2034-09-17 | Forte Biosciences Inc. | FBRX | VINCENT RICHARD G Director | 2,000 | $0 | 2,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 14,200 | $0 | 14,200 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 8,868 | $0.4961 | 147,282 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 4:59 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 738,449 | $0 | 738,467 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 4:59 pm | N/A 2029-09-12 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 738,467 | $0 | 738,467 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:58 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 7,069 | $0.36 | 156,150 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 8:00 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 210,000 | $0 | 210,000 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 6:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 4,428 | $1.02 | 133,219 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 6:19 pm | N/A 2032-07-28 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 71,875 | $0 | 166,397 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 4:00 pm | N/A 2032-01-20 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 109,579 | $0 | 109,579 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 29,867 | $0 | 77,022 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 6:00 pm | N/A 2031-02-11 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2020-03-17 Option Award(A) | 2020-07-31 9:05 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 35,120 | $0 | 35,120 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-18 6:49 pm | N/A 2030-03-17 | Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer | 35,120 | $0 | 35,120 (Direct) | View |